Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Find ways to stay ahead in budgeting with routine reviews, alerts, and smart adjustments that protect your financial path.
21,896 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Velvet has surged 1,700% in a single month, driving it into crypto headlines. Traders weigh whether momentum will sus...
A pivotal quarter could set the tone for Micron in 2026. This guide breaks down what happened, why it happened, and h...
In a volatile 2026 market, retirees are choosing stability over constant client chasing. Experts say build income fir...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
As Medicare costs rise in 2026, a diversified income plan offers a path to cover health coverage indefinitely. Expert...
A fiancé’s demand to halt gifts from a late partner’s estate sparks a debate on boundaries, prenuptial protections, a...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
Bank of America finished the Fed stress tests without a dividend hike while peers boosted payouts. Here’s what the ba...
Investors are buzzing about Micron Technology as AI and data-center demand shift the memory market. This article expl...
Retirees face uncertain cost-of-living adjustments. This guide shows you how to build retirement budget that adapts, ...
South Korea’s memory-chip giant SK Hynix plans a Nasdaq debut with a roughly $29 billion offer, aiming to test if AI-...